Top news
Texas recommends resuming Johnson & Johnson vaccine shots after CDC, FDA give green light
By Karen Brooks
Vaccinations are plateauing. Don't blame it on 'resistance'
By Stefanie Friedhoff
Federal Inspectors Fear More Vaccines Were Exposed to Contamination (Published 2021)
By Sharon LaFraniere, Chris Hamby & Sheryl Gay Stolberg
All coverage
Congressional investigation launched into Emergent BioSolutions' federal vaccine contracts
By Rich Mendez
April 23 coronavirus news
By Kara Fox, Sophie Jeong & Aditi Sangal
FDA report finds multiple failings at plant that ruined 15 million Johnson & Johnson vaccine doses
By Christopher Rowland
White House writes off Johnson & Johnson vaccine after string of production failures
By Sarah Owermohle, Adam Cancryn & Erin Banco
L.A. County prepping to resume administering Johnson & Johnson vaccine
By Luke Money & Colleen Shalby
Johnson & Johnson COVID vaccine: Pause lifted by FDA, use to resume
By Karen Weintraub & Elizabeth Weise
Johnson & Johnson Vaccine: U.S. Lifts Pause : Coronavirus Updates
By Laurel Wamsley
CDC panel voted to resume J&J COVID-19 shots paused for clot concerns
By Tina Hesman Saey
Restart of the Johnson & Johnson COVID-19 vaccine: A doctor explains why benefits far outweigh risks
By William A. Petri
U.S. ends J&J COVID-19 vaccine pause; shots to resume immediately
By Manas Mishra & Julie Steenhuysen
Emergent BioSolutions halts operations at its Baltimore plant, where J.&J. doses were ruined, at the F.D.A.'s request ...
By Sheryl Gay Stolberg
Johnson & Johnson Vaccine Will Be Available Again Soon
By Denise Grady, Julie Bosman & Noah Mercer Weiland
The F.D.A. ended its recommended pause on the J.&J. vaccine, clearing the way for states to use it again. (Published ...
By Emily Anthes, Carl Zimmer & Noah Mercer Weiland
The public's concerns over the Johnson & Johnson coronavirus vaccine are widespread, Post-ABC poll finds
By Scott Clement & Amy Goldstein